Effects of Berry Peel Intake on Glucose Metabolism in Healthy Subjects
1 other identifier
interventional
23
1 country
1
Brief Summary
The main objective of this study is to investigate the effect of a 4-weeks intake of berry peel powder on fasting and postprandial glucose metabolism and inflammatory markers. The berry peel product will be compared with a placebo in a single-blind, cross-over design. Furthermore, inflammation-related peripheral blood mononuclear cells (PBMCs) genes expression, appetite and cognitive performance will be included as a pilot study. Investigators hypothesize that long-term consumption of polyphenols and fibres of berry peel will exhibit both direct and indirect actions in healthy overweight subjects by improvement of glucose-associated markers as well as ameliorating inflammation. Moreover, above metabolic markers will correlated with improvements in inflammation-related PBMCs genes expression, subjective appetite and cognitive performance after long-term consumption of berry peel as a source of polyphenols.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1 healthy
Started Aug 2015
Typical duration for phase_1 healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 20, 2015
CompletedFirst Posted
Study publicly available on registry
August 27, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedFebruary 11, 2016
February 1, 2016
4 months
August 20, 2015
February 10, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postprandial blood glucose response after acute intervention
The capillary blood will be collected for glucose analysis using a glucometer.
-30, 0, 15, 30, 45, 60, 120, and 180 min after challenge meal.
Incremental area under curve (iAUC) blood glucose response after long-term intervention
The capillary blood will be collected for glucose analysis using a glucometer.
4 weeks
Secondary Outcomes (13)
Postprandial serum insulin response after acute intervention
-30, 0, 15, 30, 45, 60, 120, and 180 min.
Incremental area under curve (iAUC) serum insulin response after long-term intervention
4 weeks
Postprandial subjective appetite rating after acute intervention
-30, 0, 15, 30, 45, 60, 120, and 180 min.
Incremental area under curve (iAUC) subjective appetite rating after long-term intervention
4 weeks
Postprandial C-reactive protein (CRP) after acute intervention
-30, 60, 120, and 180 min.
- +8 more secondary outcomes
Study Arms (2)
Control drink
PLACEBO COMPARATORDietary supplement: Control drink As control, subjects are asked to consume 150 ml control drink containing equal amount of insoluble fiber (cellulose) and sugar for 28 days. In addition, on days-1 and 28, subjects will receive an acute challenge of placebo drink at our clinical facility. After 30 min. control drink intake, subjects will be given standardized breakfast corresponding to 50 g available carbohydrates.
Berry peel drink
EXPERIMENTALDietary supplement: Berry peel drink Subjects are asked to consume 150 ml experimental drink containing a berry peel fruit powder. In addition, on days-1 and 28, subjects will receive an acute challenge of test drink at our clinical facility. After 30 min. berry drink intake, subjects will be given standardized breakfast corresponding to 50 g available carbohydrates.
Interventions
Eligibility Criteria
You may qualify if:
- Healthy males and females
- Signed informed consent
- BMI 25-30 kg/m2
- Must be able to accept plant-based foods/drinks
You may not qualify if:
- Below 18 years or above 40 years
- Smoking or using snuff
- vegetarian or vegan
- Stressed by venous blood sampling or previous experience of being difficult canulation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lund Universitylead
- University of Campinas, Brazilcollaborator
- Conselho Nacional de Desenvolvimento Científico e Tecnológicocollaborator
Study Sites (1)
Food for Health Science Centre (Medicon Village) - Lund University
Lund, Skåne County, 221 00, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Angela G Batista, MSc
Lund University; University of Campinas
- STUDY CHAIR
Yoghatama Cindya Zanzer, MSc
Lund University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof., PhD
Study Record Dates
First Submitted
August 20, 2015
First Posted
August 27, 2015
Study Start
August 1, 2015
Primary Completion
December 1, 2015
Study Completion
January 1, 2016
Last Updated
February 11, 2016
Record last verified: 2016-02